TB Research

Epidemiology of molecular probes in Xpert MTB/RIF assay in Khyber Pakhtunkhwa, Pakistan

Khan AS, Khan MT, Ali S, Khan TA, Qasim M, Malik A, Ali S, Sajjad W, et al. (10 authors)

Archives of microbiology · 2021-02

Abstract

Regardless of a plethora of advanced diagnostics, TB and drug resistance remains a principal killer. We proposed gold nanoparticles (AuNPs) attached with probes to enhance the efficiency of GeneXpert MTB/RIF assay instead of conventional dye probes for molecular detection. A total of 15,000 samples were collected from TB suspects and subjected to Xpert MTB/RIF assay, where 6800 (45.3%) were detected as MTB positive, 280 (4.3%) were detected to harbor mutations in the RRDR, while invalid /errors were found in 690 (4.6%) cases. The mutations were detected by probe E, 199 (71.1%), while probes B and D, 30 and 26 (10% and 9%), respectively. In the Xpert MTB/RIF Assay were found mutations picked by probes E and B codons 529-533 (71%) and 512-518 (10%), respectively. The fast-rising works of TB nano-diagnostics, of Xpert probes, may improve by the applications of gold nanoparticle probes.

MeSH terms

  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis, Multidrug-Resistant
  • Tuberculosis, Pulmonary
  • Gold
  • Rifampin
  • Codon
  • Antibiotics, Antitubercular
  • Molecular Probes
  • Sensitivity and Specificity
  • Drug Resistance, Multiple, Bacterial
  • Mutation
  • Pakistan
  • Metal Nanoparticles